IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Pharma Fine Chemicals Roundup

12:50 PM MDT | June 9, 2011 | Deepti Ramesh

Johnson Matthey's Profits Rise on Improved Demand Kerri Walsh Johnson Matthey reported net income for its fiscal year ended March 31, 2011 up 11%, to £182.7 million ($299.4 million), on sales up 27%, to £10 billion. Operating income rose 12%, to £281.2 billion. Sales excluding precious metals soared 29%, to £7.7 billion. Fine chemical sales rose by 11% because of increasing demand for its active pharmaceutical ingredients. SAFC Partners with Pfenex to Codevelop Biopharmaceuticals Alex Scott Pfenex (San Diego), an expert in protein...

This information is only available to Chemical Week subscribers.

Username:
Password:

Forgot your user ID or password?
Click here to have it sent to you.

Risk Free Trial

Email Address

First Name

Last Name

Click here to register and get your RISK-FREE access to chemweek.com

Not an IHS Chemical Week
24/7 member yet?

Here's why you should be:

  • Searchable online archive access of the last 2 years of Chemical Week.
  • Print or digital magazine subscription
  • Price and market change alerts
  • Economic data and statistics
  • Buyers' Guides
  • Webcasts | whitepapers

 

 

 













 
contact us | about us | customer care | privacy policy | sitemap | advertise

ihsCopyright © 2012 IHS, Inc. All rights reserved. Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa